UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Problems in Standardizing Methods for Evaluating the Chilling Requirements for the Breaking of Dormancy in Buds of Woody Plants

HortScience, 2003-06, Vol.38 (3), p.347-350

Dennis, F.G.

2003

Volltextzugriff (PDF)

Human iPSC-derived preclinical models to identify toxicity of tumor-specific T cells with clinical potential

Molecular therapy. Methods & clinical development, 2023-03, Vol.28, p.249-261

2023

Volltextzugriff (PDF)

A library of cancer testis specific T cell receptors for T cell receptor gene therapy

Molecular therapy. Oncolytics, 2023-03, Vol.28, p.1-14

2023

Volltextzugriff (PDF)

A library of cancer testis specific T cell receptors for T cell receptor gene therapy

Molecular therapy. Oncolytics, 2023-12, Vol.31, p.100738, Article 100738

2023

Volltextzugriff (PDF)

Unravelling osteoarthritis-related synovial fibrosis: a step closer to solving joint stiffness

Rheumatology (Oxford, England), 2015-11, Vol.54 (11), p.1954-1963

2015

Volltextzugriff (PDF)

Simultaneous Deletion of Endogenous TCRαβ for TCR Gene Therapy Creates an Improved and Safe Cellular Therapeutic

Molecular therapy, 2020-01, Vol.28 (1), p.64-74

2020

Volltextzugriff (PDF)

Inhibition of SUMOylation enhances DNA hypomethylating drug efficacy to reduce outgrowth of hematopoietic malignancies

Leukemia, 2023-04, Vol.37 (4), p.864-876

2023

Volltextzugriff (PDF)

T Cell Receptor-Based Targeting of Immunoglobulin Constant Domains for Treatment of Multiple Myeloma

Blood, 2022-11, Vol.140 (Supplement 1), p.10292-10293

2022

Volltextzugriff (PDF)

Increase in ALK1/ALK5 Ratio as a Cause for Elevated MMP-13 Expression in Osteoarthritis in Humans and Mice

The Journal of immunology (1950), 2009-06, Vol.182 (12), p.7937-7945

2009

Volltextzugriff (PDF)

Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure

Oncoimmunology, 2022-12, Vol.11 (1), p.2033528-2033528

2022

Volltextzugriff (PDF)

A broad and systematic approach to identify B cell malignancy-targeting TCRs for multi-antigen-based T cell therapy

Molecular therapy, 2022-02, Vol.30 (2), p.564-578

2022

Volltextzugriff (PDF)

Broadly Applicable TCR Based Therapy for Multiple Myeloma Targeting the Jchain

Blood, 2022-11, Vol.140 (Supplement 1), p.4498-4499

2022

Volltextzugriff (PDF)

Antibody-mediated delivery of viral epitopes to redirect EBV-specific CD8+ T-cell immunity towards cancer cells

Cancer gene therapy, 2024-01, Vol.31 (1), p.58-68

2024

Volltextzugriff (PDF)

Self-sufficient primary natural killer cells engineered to express T cell receptors and interleukin-15 exhibit improved effector function and persistence

Frontiers in immunology, 2024-04, Vol.15, p.1368290-1368290

2024

Volltextzugriff (PDF)

Cutting Edge: Unconventional CD8 + T Cell Recognition of a Naturally Occurring HLA-A02:01-Restricted 20mer Epitope

The Journal of immunology (1950), 2022-04, Vol.208 (8), p.1851-1856

2022

Volltextzugriff (PDF)

PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer

Frontiers in immunology, 2023-03, Vol.14, p.1121973-1121973

2023

Volltextzugriff (PDF)

TGF-ß induces Lysyl hydroxylase 2b in human synovial osteoarthritic fibroblasts through ALK5 signaling

Cell and tissue research, 2014, Vol.355 (1), p.163-171

2014

Volltextzugriff (PDF)

Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain

Journal of hematology and oncology, 2023-02, Vol.16 (1), p.16-16, Article 16

2023

Volltextzugriff (PDF)

T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion

Journal for immunotherapy of cancer, 2022-03, Vol.10 (3), p.e003715

2022

Volltextzugriff (PDF)

Combining BCMA-targeting CAR T cells with TCR-engineered T-cell therapy to prevent immune escape of multiple myeloma

Blood advances, 2023-10, Vol.7 (20), p.6178-6183

2023

Volltextzugriff (PDF)

WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma

Journal for immunotherapy of cancer, 2022-06, Vol.10 (6), p.e004409

2022

Volltextzugriff (PDF)

VISTA Expression on Cancer-Associated Endothelium Selectively Prevents T-cell Extravasation

Cancer immunology research, 2023-11, Vol.11 (11), p.1480-1492

2023

Volltextzugriff (PDF)

An HLA-A11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AML

Cancers, 2021-10, Vol.13 (21), p.5390

2021

Volltextzugriff (PDF)

Response of Several Apple Cultivars to Thinning Sprays of Benzyladenine, NAA, Carbaryl, and Combinations Thereof

HortScience, 1995-07, Vol.30 (4), p.765-765

Dennis, F.G.

1995

Volltextzugriff (PDF)

Fruit development

Dennis, F.G. Jr

1984

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(58)

Publikationsform

Sprache

Englisch
(89)

Erscheinungsjahr

n.n

Thema

Science & Technology
(59)
Life Sciences & Biomedicine
(41)
Horticulture
(19)
Agriculture
(17)
Humans
(13)
Biological And Medical Sciences
(12)
Fundamental And Applied Biological Sciences. Psychology
(11)
Agronomy. Soil Science And Plant Productions
(10)
Physical Sciences
(10)
Economic Plant Physiology
(9)
Oncology
(9)
Immunology
(8)
Growth And Development
(7)
Animals
(6)
Astronomy & Astrophysics
(6)
Cd8-Positive T-Lymphocytes
(6)
Immunotherapy
(6)
Multiple Myeloma
(6)
Technology
(6)
Hematology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Problems in Standardizing Methods for Evaluating the Chilling Requirements for the Breaking of Dormancy in Buds of Woody Plants

Human iPSC-derived preclinical models to identify toxicity of tumor-specific T cells with clinical potential

A library of cancer testis specific T cell receptors for T cell receptor gene therapy

A library of cancer testis specific T cell receptors for T cell receptor gene therapy

Unravelling osteoarthritis-related synovial fibrosis: a step closer to solving joint stiffness

Simultaneous Deletion of Endogenous TCRαβ for TCR Gene Therapy Creates an Improved and Safe Cellular Therapeutic

Inhibition of SUMOylation enhances DNA hypomethylating drug efficacy to reduce outgrowth of hematopoietic malignancies

T Cell Receptor-Based Targeting of Immunoglobulin Constant Domains for Treatment of Multiple Myeloma

Increase in ALK1/ALK5 Ratio as a Cause for Elevated MMP-13 Expression in Osteoarthritis in Humans and Mice

Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure

A broad and systematic approach to identify B cell malignancy-targeting TCRs for multi-antigen-based T cell therapy

Broadly Applicable TCR Based Therapy for Multiple Myeloma Targeting the Jchain

Antibody-mediated delivery of viral epitopes to redirect EBV-specific CD8+ T-cell immunity towards cancer cells

Self-sufficient primary natural killer cells engineered to express T cell receptors and interleukin-15 exhibit improved effector function and persistence

Cutting Edge: Unconventional CD8 + T Cell Recognition of a Naturally Occurring HLA-A02:01-Restricted 20mer Epitope

PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer

TGF-ß induces Lysyl hydroxylase 2b in human synovial osteoarthritic fibroblasts through ALK5 signaling

Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain

T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion

Combining BCMA-targeting CAR T cells with TCR-engineered T-cell therapy to prevent immune escape of multiple myeloma

WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma

VISTA Expression on Cancer-Associated Endothelium Selectively Prevents T-cell Extravasation

An HLA-A11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AML

Response of Several Apple Cultivars to Thinning Sprays of Benzyladenine, NAA, Carbaryl, and Combinations Thereof

Fruit development

Suchergebnisse filtern